Morning Overview on MSN
The ETH Zurich team behind the new Alzheimer’s compound is hunting a drugmaker to carry it forward
Researchers at ETH Zurich have identified a compound that targets a previously overlooked protein aggregation mechanism in ...
Researchers created Compound 10 to block GRK2 enzyme aggregation and protect mitochondria in Alzheimer's disease.
Research appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a ...
Bifloranes, also known as serrulatanes, feature a distinct 6,6-bicyclic framework and a prenyl side chain, showcasing a wide range of biological activities such as anti-inflammatory, antimalarial, and ...
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Silvio Di Castro, Senior Technology Scientist at AstraZeneca, about his research, as well as the role of compound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results